Navigation Links
Iomai Receives HHS Approval to Begin Phase 2 Trial of H5N1 Influenza Adjuvant Patch
Date:4/15/2008

- Dose-Ranging Trial to Further Assess Feasibility of Dose-sparing and

Single-Dose Vaccination Against H5N1 Flu -

GAITHERSBURG, Md., April 15 /PRNewswire-FirstCall/ -- Iomai Corporation (Nasdaq: IOMI) today announced that it has received approval from the Department of Health and Human Services (HHS) to expand its program to develop an immunostimulant adjuvant patch for use with an injected H5N1 influenza vaccine. This decision was based upon positive clinical data generated in a 500-subject, Phase 1/2 study recently completed by Iomai.

Guided by data from this study, Iomai will begin a Phase 2 dose-ranging study designed to identify the optimum dose of antigen and adjuvant that can be used in a one-dose or two-dose regimen to enhance the immune response to a H5N1 influenza vaccine. As the majority of current approaches to pandemic influenza vaccines require two doses, given 3 or 4 weeks apart, a single-dose strategy would significantly simplify the logistics of a mass vaccination program.

Last month, Iomai announced the results of the first clinical trial of the patch when used with an injectable H5N1 influenza vaccine. That trial found that a single 45-microgram dose of an H5N1 influenza vaccine, coupled with a single 50-microgram Iomai adjuvant patch, was sufficient to provide an immune response considered protective in 73 percent of those tested, a statistically significant improvement over those who received the H5N1 influenza vaccine alone. A second dose of both vaccine and patch further enhanced immunogenicity; 100 percent of subjects who received two 45-microgram doses of vaccine and two Iomai patches had a measurable immune response, and 94 percent of these subjects had immune responses cons
'/>"/>

SOURCE Iomai Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
2. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC
3. Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
4. Iomai CEO to Speak at Acumen BioFin Rodman & Renshaw Annual Healthcare Conference on Monday, Nov. 5
5. Iomai and Merck & Co., Inc. Evaluate Use of Iomai Immunostimulant Patch
6. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
7. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
8. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
9. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
10. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
11. CryoCor Receives FDA Approval for Right Atrial Flutter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... 2014 BerGenBio AS, a biopharmaceutical ... resistant cancers, today announces that it has raised NOK90 ... new and existing investors. BerGenBio will use ... of its pipeline of innovative cancer therapeutics, in particular ... candidate, BGB324, a first-in-class selective Axl kinase inhibitor, which ...
(Date:12/15/2014)... and Washington State are not the ... Oregon , Alaska , and ... November 2014 elections. Photo - http://photos.prnewswire.com/prnh/20141212/164152 ... The benefits of legalizing cannabis are manifold. There are ... tax revenue for state and local governments, in addition to ...
(Date:12/15/2014)...   DaVita HealthCare Partners Inc.  (NYSE: ... and most innovative health care communities, today announced ... Clinical Research  (DCR) and  HealthCare Partners Clinical Research , ... clinical research and data analytics services, specifically in ... renal disease (ESRD), as well as primary care ...
Breaking Medicine Technology:BerGenBio Completes NOK90 Million Fundraising 2CannaInsider.com Estimates 200,000 New Jobs in the Cannabis Industry by 2015 2DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 2DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 3DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 4
... GAITHERSBURG, Md., June 27, 2011 /PRNewswire-USNewswire / -- ... new service for people with Acute Lymphoblastic Leukemia ... refund eligible patients 100 percent of any co-pay ... information on eligibility criteria, please call 1-800-490-3262, Monday ...
... of two studies testing drugs to slow or stop ... newly diagnosed with type 1 diabetes will be presented ... in San Diego and simultaneously published online in the ... National Institutes of Health,s international network of researchers, Type ...
Cached Medicine Technology:Financial Assistance Now Available for People with Acute Lymphoblastic Leukemia 2Financial Assistance Now Available for People with Acute Lymphoblastic Leukemia 3Financial Assistance Now Available for People with Acute Lymphoblastic Leukemia 4Two Studies Test Impact of Drugs to Slow Progression of Type 1 Diabetes 2Two Studies Test Impact of Drugs to Slow Progression of Type 1 Diabetes 3Two Studies Test Impact of Drugs to Slow Progression of Type 1 Diabetes 4
(Date:12/15/2014)... Street Dental Team ( http://www.MainStreetDentalTeam.com ), Unionville’s first full-time ... providing evidence on the impact of 100% pure fruit ... enough evidence already exists showing a negative link between ... the onset of tooth decay. One question that has ... fruit juice, meaning it is completely natural with no ...
(Date:12/15/2014)... OutMarket , a provider of ... Media Cheat Sheets ,” a guide that exposes the ... on the top ten social media networks. , ... awareness, engagement, and customer service. It can also increase ... impact on new networks and weather constantly changing algorithms, ...
(Date:12/15/2014)... -- Expert pilots process visual information more efficiently than ... decisions during landings, a new study shows. Landing ... to master, and 36 percent of all airplane crashes ... approach and landing. Researchers monitored the brain activity ... while they were at the controls of a flight ...
(Date:12/15/2014)... December 15, 2014 Emergo Group, Inc., ... 26 countries in North and South America, Europe, the ... from industry participants for its 2015 Medical Device Industry ... to identify upcoming business and market trends as well ... The survey targets areas including:, , ...
(Date:12/15/2014)... 15, 2014 Bacteroides is becoming the indicator ... it much more prevalent than coliforms, it cannot reproduce in ... environment. , Key Benefits of the new Bacteroides Sewage ... , Eliminates false positives from coliforms naturally occurring ... , Maintain the same sampling method with ...
Breaking Medicine News(10 mins):Health News:Main Street Dental Team, Unionville’s Most Innovative Dental Clinic, Comments on New Study Relating Pure Fruit Juice to Poor Oral Hygiene 2Health News:OutMarket Releases Cheat Sheets for Social Media Marketing 2Health News:OutMarket Releases Cheat Sheets for Social Media Marketing 3Health News:Study Shows Why Expert Pilots Are Experts 2Health News:Emergo’s Annual Survey Assessing the State of the Medical Device Industry Now Open 2
... Neurosurgeons from NYU Langone Medical Center will present research ... to treat neurosurgical conditions at the annual meeting of ... 14-18, 2012 in Miami Beach, FL. NYU Langone faculty ... at AANS, including: *Craino-Cervical and C1C2 Stabilization ...
... Virginia Commonwealth University School of Medicine researchers have discovered ... may contribute to high blood pressure and increase susceptibility to ... findings could provide clues to the best treatment approaches for ... can block blood flow to a pregnant woman,s internal organs ...
... Steven Reinberg HealthDay Reporter , THURSDAY, April ... called phthalates, which are found in soaps, lotions, plastics ... diabetes among older adults, Swedish researchers say. "Our ... contribute to the development of diabetes," said lead researcher ...
... , THURSDAY, April 12 (HealthDay News) -- Genetic evidence ... a new study says. The finding is significant because ... not, the researchers explained. The researchers compared the number ... life-cycle stage of head and body lice and found that ...
... in how exercise affects menopausal women, according to Penn ... one experiences more hot flashes after physical activity, while ... that seemed to differentiate the two groups was perceived ... of kinesiology. "These women have ways of dealing with ...
... Dotinga HealthDay Reporter , THURSDAY, April 12 (HealthDay ... stress, a new study from Denmark finds that the marriages ... likely to fall apart. The study debunks "a persistent ... one,s marriage and family. This is simply not true," said ...
Cached Medicine News:Health News:NYU Langone experts present research, clinical advances at neurosurgeons meeting 2Health News:Changes in gene expression may help explain high blood pressure in pregnancy 2Health News:Common Plastics Chemical Might Boost Diabetes Risk 2Health News:Common Plastics Chemical Might Boost Diabetes Risk 3Health News:Exercise and attitude may be thermostat for hot flashes 2Health News:Parents of Kids With Cancer No More Likely to Break Up 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: